Prostate Cancer Case Presentation Shireen Siddiqui.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Advances in the Management of BPH
Current Opinion in Urological Cancer
Investigation and Management of Prostate Cancer
A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Acute Urinary Retention
Phase 2 Patrick King The Peer Teaching Society is not liable for false or misleading information…
US TOO INTERNATIONAL, INC US TOO GREATER QUAD CITIES PROSTATE CANCER SUPPORT GROUP.
Non Acute Scrotal Swelling
Supervised by: Dr- Al Traifi. Why LUTS? What are the symptoms? Common causes? Patient work up Details of the Common etiology BPH.
MODULE 5 1/40 Case 3: Chuck. MODULE 5 Case 3: Chuck 2/40 Patient History  Chuck is a 66 year old retired chemical compounder  He is distressed by the.
Neurourology Panele Sakineh Hajebrahimi Associate Professor of Urology TUMS.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
MODULE 5 1/26 Case 6: Anthony. MODULE 5 Case 6: Anthony 2/26 Patient History  Anthony is a 55-year old lawyer.  He has been suffering from voiding complaints.
CA of Prostate:Incidence In a 50 y/o man In a 50 y/o man In autopsy: 40% In autopsy: 40% Clinical: 10% Clinical: 10% Death: 3% Death: 3% Most common non-cutanous.
AM Report 9/11/09 Prostate Cancer Julia Rauch. Disease Burden ~220,000 men were diagnosed with prostate cancer in 2007 ~1/6 men will receive the disagnosis.
Lower urinary tract symptoms (LUTS) in elderly males
Prostate Cancer. Statistics of prostate cancer Incidence Prostate- 32% Lung – 16% Mortality Lung- 33% Prostate 13%
Lower Urinary Tract Symptoms (LUTS) in men Kamal Patel GPST2.
2008. Causes of symptoms  Hyperplasia of epithelial and stromal components of prostate  Progressive obstruction of urinary outflow  Increased activity.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
PROSTATE PATHOLOGY Emad Raddaoui, MD, FCAP, FASC 1.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
Akbar Ashrafi Surgical Students Society of Melbourne September 2010.
Adult Medical - Surgical Nursing
Prostate Cancer By: Kurt Rishel.
Dr Charles Chabert Urinary Symptoms &GreenLight Laser Prostatectomy.
Should I have that blood test for Prostate Cancer?
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Benign Prostatic Hyperplasia
Pathology of Prostate Gland
Urology Update Sanofi- Aventis
Asim Pasha.  Common condition seen in older men  Risk factors  1-age:  Around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms.
Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
Case Presentation HKC A 78 y/o man obstructive symptoms Flank pain(_) Gross hematuria(-). LUTS(+)
A 74 year old man underwent open prostatectomy due to moderate to severe urinary symptoms unresponsive to medical therapy. Preoperative PSA was 4.1 Postoperatively.
Carcinoma of prostate 1. Incidence ❏ most prevalent cancer in males ❏ second leading cause of male cancer deaths ❏ lifetime risk of a 50 years man for.
Bladder cancer. Urothelial tumors -90% in bladder -8% renal pelvis -2% ureters and urethra.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
Male Reproductive System Kristine Krafts, M.D.. Male Reproductive System Outline Testis Prostate.
COSULTANT UROLOGIST.  Diseases of lower urinary tract.
Prostate Cancer. What is the Prostate Gland What is the prostate Gland Size of a chestnut Just beneath the bladder Urethra runs through its middle Its.
BLADDER OUTLET OBSTRUCTION (B.O.O.). BOO It’s urodynamic concept of low flow rates and high intravesical pressures. Causes: *BPH. *CAP. *bladder neck.
NICE GUIDELINES FOR SUSPECTED CANCER: RECOGNITION AND REFERRAL JUNE 2015 UROLOGY SSG MEETING 15 October 2015 Jamal Ghaddar, Matthew Goh Department of Urology.
Urological Cancer Kieran Jefferson Consultant Urological Surgeon
Genitourinary Blueprint
Pathology of the Urogenital Tract Male Genital Tract March 24, 2014.
Carcinoma of Bladder & Prostate BPH
Men’s health. Mr Williams Mr Williams is 56, African-Caribbean and comes to see you with a 6month history of increasing difficulty passing urine and nocturia.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Prostate Cancer Awareness In association with. What is Prostate Cancer?
Prostate Cancer David Eedes 11 May Prostate Cancer Definition: Prostate cancer is a disease in which cells in the prostate gland become abnormal.
Carcinoma of Prostate Issam S. Al-Azzawi, MD,FICMS,FEBU By
TUCOM Internal Medicine 4th class
Male Reproductive System
Carcinoma of the Prostate
Bladder Cancer and Prostatic Cancer
Prostate Cancer Dr .Gehan Mohamed.
Prostate Cancer: Highlights from 2006
Antonio Alcaraz, Pierre Teillac  European Urology Supplements 
Initial Office Evaluation
A case of localized Prostate Cancer Marije Hamaker.
Standardised follow-up
Urinary Retention.
Presentation transcript:

Prostate Cancer Case Presentation Shireen Siddiqui

Prostate Cancer  Commonest cancer in UK men  Majority are well defined adenocarcinomas  Rare in <50y  Often present with metastases  5 year survival rate approx 30%

Clinical Features  BOO symptoms:  Voiding symptoms: hesitancy, poor flow  Storage symptoms: frequency, urgency  Haematuria  Back pain  Constipation  General effects of malignancy  Symptoms suggestive of metastases

PSA Ranges Age/ yearsPSA level/ ng/ml >70>5.0 No age-specific reference ranges for men over 80 years. Nearly all men of this age have at least a focus of cancer in the prostate. Prostate cancer only needs to be diagnosed in this age group if it is likely to need palliative treatment.

Gleason Staging  5 histological stages of differentiation  Two numbers, most prevalent and the 2 nd most prevalent pattern give the Gleason score  5-6  Lower progression rates after definitive therapy  7-10  Worse prognosis

Treatment  Organ defined:  Active surveillance  Radical prostatectomy  Locally advanced:  Systemic treatment: hormone therapy  Radiotherapy  LHRH agonist – Zoladex  Metastatic:  LHRH agonist  Anti-androgen therapy - Bicalutamide  Bilateral orchidectomy  Chemotherapy

Case History  80 year old male  Fit and well  No PMHx  No DHx  Lives with wife

PC  Urinary urgency and frequency  Wife felt he was more confused  Returned from holiday, drove 1100 miles  Positive urine dip, started on abx  MSU: E. coli  r/v 1 week

1 week later  Confusion had settled  Felt much better  Nocturia, urinary incontinence, poor stream  Usually no LUTS  Ex:  DRE: enlarged prostate, irregular on left  Abdo: distended, enlarged bladder  1.5l residual

Results PSA27.10  Hb13.1 WCC18.70  neut17.1 Repeat MSU: Klebsiella species

2WW Urology  Likely spurious PSA level  Failed TWOC  Arranged cystoscopy: bladder NAD  Prostate biopsies taken

2WW Urology  Prostate Ca confirmed :  Gleason 5+4  Commenced on Cyproterone acetate  Bone scan:  Metastases to thoracic spine, left iliac crest, sacrum, 3 rd right rib

Currently  Doing well, not needing any analgesia  SRC still in place  On 3 monthly Prostap injections

My learning points  Why does he have a UTI?  Possible bladder outflow obstruction.  Enlarged prostate?  Examine abdomen.

2WW Urology Criteria-?Prostate Ca  With a hard, irregular prostate typical of a prostate carcinoma  With a normal prostate, but rising/raised age-specific PSA, with/without LUTS  With symptoms and high PSA levels

Summary  Prostate cancer is the commonest cancer in men in the UK  Can present with LUTS, UTI, no symptoms, but most often with metastases  Consider cause for UTI, ?BOO

Any questions?